FDA Approves Avastin in Combination with Chemotherapy as Treatment for Advanced Ovarian Cancers

FDA Approves Avastin in Combination with Chemotherapy as Treatment for Advanced Ovarian Cancers
The U.S. Food and Drug Administration (FDA) has approved the use of Avastin (bevacizumab) in combination with standard chemotherapy, followed by Avastin alone, as a front-line treatment for advanced ovarian cancers. This label extension is for women who have already undergone surgery and represents Avastin’s fourth indication as a treatment for gynecologic cancers. These include the

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *